Indian heart journal
-
Indian heart journal · Nov 2008
Randomized Controlled Trial Clinical TrialNonresponders to clopidogrel therapy among Indian patients undergoing elective/adhoc angioplasty.
Clopidogrel has become the standard antiplatelet drug along with aspirin in patients undergoing coronary angioplasty; however, data regarding the nonresponse rate to clopidogrel therapy in Indian patients are limited. ⋯ Clopidogrel nonresponse is prevalent among Indian patients, and there is wide interpatient variability in platelet inhibition among individual patients. However, the clinical implications of these findings need to be substantiated in larger studies with clinical end points.